Article Details

bluebird bio (NASDAQ:BLUE) Rating Lowered to Neutral at JPMorgan Chase & Co.

Retrieved on: 2024-08-16 03:43:54

Tags for this article:

Click the tags to see associated articles and topics

bluebird bio (NASDAQ:BLUE) Rating Lowered to Neutral at JPMorgan Chase & Co.. View article details on hiswai:

Excerpt

AQR Capital Management LLC now owns 1,334,519 shares of the biotechnology company's stock worth $1,223,000 after buying an additional 1,013,144 shares ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up